Dr. Nhiem Tran is a Senior Lecturer in the Department of Applied Chemistry and Environmental Science at RMIT University's School of Science, part of the STEM College. He joined RMIT in 2015 as a Vice Chancellor's Research Fellow after completing his PhD in Physics at Brown University (USA, 2012) and postdoctoral research at Rhode Island Hospital (USA), CSIRO, and the Australian Synchrotron. His research focuses on developing biomaterials for drug delivery, gene therapy, and medical implants, particularly lipid nanoparticles and 3D-printed metallic implants. He leads the Biomaterial Interfaces group, investigating self-assembled lipid nanoparticles for cancer and autoimmune disease treatments. His work has resulted in over 65 high-impact publications and numerous awards, including the RMIT Vice Chancellor's Research Fellowship and the Stein/Bellet Foundation Fellowship. Tran's funding comes from grants such as the ARC Discovery Project, mRNA Victoria, and the CASS Foundation. His research interests span nanomedicine, biomedical engineering, and materials science, with a focus on applications in drug delivery, bacterial infection control, and orthopaedic implants. Education: PhD in Physics (Brown University, 2012) Key Projects: 3D-printed diamond-titanium implants, lipid nanoparticle drug carriers, and antimicrobial coatings. He actively supervises postgraduate research in areas like nanomaterials for drug delivery and biomedical applications.
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
George T.-C. Chiu is a Professor in the School of Mechanical Engineering at Purdue University, with courtesy appointments in Electrical and Computer Engineering and Psychological Sciences. He holds a 50% appointment as Assistant Dean for Global Engineering Programs and Partnerships. Previously, he served as a Program Director at the NSF, managing the Control Systems Program and National Robotics Initiative. His research focuses on mechatronics, dynamical systems, and control, with applications in printing, robotics, and human-machine interaction. Education: PhD (1994), University of California, Berkeley MS (1990), University of California, Berkeley BS (1985), National Taiwan University Research Interests: Functional printing technologies for biomedical and environmental sensors Robotics and human-robot interaction Control systems for manufacturing and dynamic systems Energy-efficient sensor design His work bridges mechanical engineering, materials science, and control theory, addressing challenges in precision manufacturing and sustainable technology. Awards: Fellow, ASME (2021) Fellow, Society for Imaging Science and Technology Grants & Projects: USDA-funded projects on food safety sensors and sustainable agriculture NSF initiatives in robotics and additive manufacturing Collaborative research with industry partners like HP and the Army Labs & Outreach: Founded the Purdue FIRST Programs, mentoring K-12 students in robotics. Co-developed experiential courses for student mentors, fostering leadership and project management skills.
JIANG Xingyu is Chair Professor and Head of the Department of Biomedical Engineering at the Southern University of Science and Technology (SUSTech) . Since 2018 he has led a multidisciplinary team developing advanced micro- and nano-scale tools for analytical chemistry, microfluidics and nanomedicine. Education Postdoctoral Research, Harvard University (2004–2005) Ph.D. in Chemistry, Harvard University (2004) B.S. in Chemistry, University of Chicago (1999) Research Interests Professor Jiang’s research integrates analytical chemistry , microfluidics , biomedical engineering and nanomedicine . His laboratory designs microfluidic chips for point-of-care diagnostics, engineers gold nanoclusters and nanoparticles for antimicrobial and anticancer therapy, and develops soft flexible bio-electronics for neural interfaces and wearable health monitoring. Across 400+ publications, recent work demonstrates a clear trend toward translational nanomedicine : point-of-care viral variant detection, nanoantibiotic strategies against multidrug-resistant bacteria, CRISPR delivery systems for cancer therapy, and conformal electronic tattoos for human-machine interfaces. Scientific Awards & Honours Fellow, American Institute for Medical and Biological Engineering (2020) Fellow, Royal Society of Chemistry (2016) Tencent Science Exploration Award (2019) Chief Scientist, National Key R&D Program (2019–) National Science Fund for Distinguished Young Scholars (2010) Young Investigator Award, Human Frontier Science Program (2007) Research Funding & Teams He currently directs the Nanoscience Laboratory at SUSTech, hosts National Key R&D Program projects as Chief Scientist, and serves on editorial boards of Advanced Healthcare Materials , Lab on a Chip , Nanoscale Horizons , Nanoscale and Nanoscale Advances . The group is actively recruiting post-docs, research professors and technicians across chemistry, materials, biology and medical engineering disciplines.
Prof. Dr. Jing Wang is a Full Professor at the Department of Civil, Environmental and Geomatic Engineering at ETH Zürich. His research focuses on air pollution control, nanoparticle transport, and environmental health and safety (EHS) impacts of nanomaterials. He has held roles including Assistant Professor at ETH Zürich (2010–present), Research Assistant Professor at the University of Minnesota (2007–2010), and postdoctoral associate in Particle Technology (2005–2007). Education: Bachelor’s in Engineering (2000) – Tsinghua University, Beijing Master’s in Computer Sciences (2003) – University of Minnesota PhD in Aerospace Engineering (2005) – University of Minnesota Research Interests: Air/water filtration technologies Nanoparticle emission reduction and measurement Multiphase flow mechanics Environmental impacts of nanomaterials Collaborations: Industrial partnerships include 3M, BASF, Boeing, Intel, Samsung, and others in nanoparticle measurement and filtration solutions. Honors: 2011 Smoluchowski Award (Association for Aerosol Research) 2006 ‘Best Dissertation’ Award (University of Minnesota) 2004 Doctoral Dissertation Fellowship Teaching: Courses include Air Pollution Control, Environmental Engineering Seminars, and Excursions for Environmental Engineers. Labs/Teams: Leads the Particle Technology Lab and collaborates with the Institute of Environmental Engineering at ETH Zürich.
David J. Crandall is the Luddy Professor of Computer Science at Indiana University's Luddy School of Informatics, Computing, and Engineering. He serves as Director of the Luddy Artificial Intelligence Center and leads the IU Computer Vision Lab. With joint appointments in Informatics, Cognitive Science, Data Science, and Statistics, his work spans computer vision, machine learning, and AI. He holds a Ph.D. from Cornell University and previously worked at Eastman Kodak Research Labs. His research focuses on developing statistical and machine learning methods to analyze visual information, including object recognition, human activity analysis in video, 3D reconstruction, social media mining, and computational studies of visual attention. Key applications include egocentric vision systems, social robotics for healthcare, and cross-disciplinary collaborations with developmental psychology. Recent publications demonstrate strong emphasis on egocentric video analysis (Ego4D), human-robot interaction (CHI/HRI), and explainable AI (IJCAI). Medical imaging, nanoscale security systems, and computational social science represent emerging interdisciplinary directions. His work consistently integrates deep learning with real-world applications in health, environmental monitoring, and cultural analytics. Tracy M. Sonneborn Award (2024) Distinguished Member of the ACM (2023) Luddy Professorship (2021) NSF CAREER Grant (2013) Trustees Teaching Award (2017) He has advised over 20 Ph.D. graduates, with current students working on computer vision, robotics, and AI ethics. Major grants include $20M for the NSF AI Institute on Engaged Learning, $4.4M for trusted AI research, and funding from NIH, Google, ONR, and NASA. He directs the Computer Vision Lab and collaborates with Selma Sabanović's robotics group on social agents for older adults.
Dr. Daniel Roxbury is an Associate Professor and Graduate Director at the Department of Chemical, Biomolecular and Materials Engineering within the University of Rhode Island's College of Engineering. With expertise in nanoscience and carbon nanomaterials, his research focuses on nano-bio interactions, developing functionalized nanotubes for biomedical applications and environmental monitoring through his NanoBio Engineering Laboratory. His work spans multiple disciplines including: Biomedical nanosensors Smart wearable biomaterials Targeted drug delivery systems Environmental nanotechnology Single-molecule imaging Nanotoxicology Recent publications emphasize machine learning-enhanced spectral analysis, coral reef conservation nanotechnology, and wearable stress monitoring textiles. His 2024 ACS Nano study introduces AI-driven macrophage phenotyping, while 2023 Nature Nanotechnology work explores coral reef restoration strategies using nanomaterials. Awarded the 2019 NSF CAREER grant for cellular nanometrology, he leads multiple NIH-funded projects including: $820,000 NSF CAREER: Spectral Imaging for Sub-Cellular Nanometrology $140,000 Miriam Hospital COBRE: Cortisol Detection Textiles $700,000 NSF EAGER: Multiplexed Wound Biomarker Detection His laboratory houses state-of-the-art equipment including: Near Infrared Hyperspectral Microscope Custom NIR Fluorescence Spectrometer Jasco UV/VIS/NIR Spectrophotometer Biosafety Cabinet Cell Culture Incubator Cryo-Storage System
Dr. Cooper Harshbarger is a Lecturer at the Department of Health Sciences and Technology at ETH Zurich , Switzerland. His research bridges biomechanics and acoustofluidics, focusing on spinal surgery and microscale cell manipulation technologies. Email: cooper.harshbarger@hest.ethz.ch Research Interests : Dr. Harshbarger specializes in biomechanical analysis of spinal structures and acoustofluidic device development . His work explores: Biomechanics of the lumbar spine and osteoligamentous complexes Acoustically-driven microfluidic systems for medical diagnostics Cell focusing/trapping technologies using sharp-edge acoustofluidics Scientific Contributions : Recent publications highlight his dual expertise in spinal fusion biomechanics and microscale fluid control , with applications in cancer diagnostics and cell manipulation. Key technologies include BAW-based systems and programmable acoustofluidic chips.
Jonathan Conway is an Assistant Professor in the Department of Chemical and Biological Engineering at Princeton University and an associated faculty member of the High Meadows Environmental Institute (HMEI). He leads the Conway Lab, which focuses on engineering plant-microbe interactions for applications in bioagriculture, bioenergy, and biochemical industries. Education: B.S. Chemical Engineering, University of Notre Dame (2011) M.S. Chemical Engineering, North Carolina State University (2013) Ph.D. Chemical Engineering, North Carolina State University (2017) Postdoctoral Fellow, University of North Carolina Chapel Hill & Howard Hughes Medical Institute (2017-2021) Research Interests: The Conway Lab develops genetic engineering approaches for non-model bacteria at plant-microbe interfaces. Key research areas include: chemical signaling between plants and microbes, microbiome impacts on plant immunity, environmental stress responses in agricultural systems, and enzymatic degradation of lignocellulosic biomass using thermophilic bacteria. The lab employs bacterial genetics, systems biology, and biomolecular engineering to create technologies for sustainable bioindustries. Publication Trends: Recent work demonstrates strong emphasis on molecular mechanisms of plant-microbe communication (2020-2024), enzyme characterization in biomass degradation (2024-2025), and development of synthetic microbial communities for climate resilience (2024). Earlier research focused on extremophile enzymology and metabolic engineering (2012-2019). Student Advising: Currently mentors 4 graduate students and 8 undergraduates. Alumni include 9 former advisees who graduated between 2022-2024. The lab actively recruits students through Princeton's Chemical Engineering graduate program and undergraduate research initiatives. Laboratory: The Conway Lab develops microfluidic systems for root microbiome studies and genetic tools for engineering plant-associated bacteria. Current projects include designing thermophilic microbial consortia for consolidated bioprocessing and characterizing bacterial immune evasion strategies.
Chao Wang is an Associate Professor at the Department of Chemical and Biomolecular Engineering within the Whiting School of Engineering at Johns Hopkins University. He also serves as the Director of the Nano Energy Laboratory and the department’s Master’s Admissions Director. His research focuses on sustainable energy systems and nanomaterials for CO2 capture and conversion, electrocatalysis, thermocatalysis, and green chemical engineering. Education: Bachelor’s degree, University of Science and Technology of China (2004) Doctorate, Brown University (2009) Wang’s research targets efficient energy conversion and storage via nanomaterials with tailored atomic structures, emphasizing catalytic activity, selectivity, and stability. His group explores electrochemical and thermochemical processes for reduced carbon footprints, including CO2 and methane conversion, ammonia recovery, and phosphorus/nitrogen nutrient recycling using zeolite-based systems. Recent publications (2021–2024) highlight his work in high-entropy alloys, solid-state battery materials, CO2 electroreduction, and biomedical nanotechnologies. Collaborative efforts span catalysis, nanoparticle dynamics, and environmental applications. Grants include a $1M DOE award for multi-university research, a $625K DOE grant for electrified transportation systems, and $3M in startup funding for carbon-removal technology commercialization. Alumni under his mentorship include Ph.D. graduates like Michael J. Manto (2018) and Master’s students like Mitchell Keller (2018), with notable achievements in catalyst development for ammonia/phosphorus recovery and industry placements at Grace & Co. and GEA Engineering.
Dr. G.K. Knopf is a Professor in the Department of Mechanical & Materials Engineering at Western University, Canada. He holds a Ph.D. (1991), M.Sc. (1987), and B.E. (1984) from the University of Saskatchewan. His work bridges product design, advanced manufacturing, and bio-inspired technologies. Research Focus: Dr. Knopf’s research spans 3D shape reconstruction , laser microfabrication , micro-optics , and bioelectronic imaging arrays . Recent projects emphasize light-driven actuators , flexible electronics , and graphene-based inks for printing circuits on unconventional substrates like silk and paper. Publications: Over 150 peer-reviewed works, including two edited CRC Press volumes ( Smart Biosensor Technology , Optical Nano and Micro Actuator Technology ). Key contributions involve non-lithographic fabrication , bacteriorhodopsin photodetectors , and self-organizing feature maps for data visualization. Awards/Patents: Co-inventor of two U.S. patents (6,542,249 for 3D surface measurement; 7,573,024 for bioelectronic imaging arrays). Teaching: Leads graduate courses in Medical Device Design and Optomechatronic Systems , as well as undergraduate Mechatronics and Medical Device Development courses.
Jun Liu is an Assistant Professor in the Department of Mechanical and Aerospace Engineering at the School of Engineering and Applied Sciences, University at Buffalo. His research focuses on advanced energy materials, nano/micro-mechanics, and self-powered systems, with applications in triboelectric energy harvesting and scanning probe microscopy. Education: PhD, Materials Engineering, University of Alberta (2018) MS, Materials Science, Shanghai University (2015) BE, Materials Science and Engineering, Nanchang University (2012) Research Interests: Development of tribovoltaic and triboelectric systems for self-powered electronics Mechanical energy harvesting via dynamic heterojunctions and Schottky contacts 3D-printed hydrogel structures for energy absorption and flexible electronics Nanoscale characterization using atomic force microscopy Design of nanocomposite sensors and catalytic materials Publication Trends: His work emphasizes triboelectricity, nanoscale energy conversion, and sustainable materials. Recent articles explore bionic tactile sensing, tunable hydrogels, and quantum dynamics in sliding interfaces. Awards: SONY Faculty Innovation Award (2021) Nature Springer MINE Young Scientist Award (2020) International Contest of Applications in Nano/Micro Technology Prize (2013) Laboratory: Advanced Energy Materials and Nanomechanics Lab at University at Buffalo.
Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.
Dr. Thomas A. Hughes is an Associate Professor of Cancer Biology at the University of Leeds and Professor of Biosciences at York St John University. As a Group Leader at the Leeds Institute of Medical Research, he focuses on gene regulation, tumour microenvironment, and nanomedicine approaches to improve cancer outcomes. Specializes in breast cancer, colorectal cancer, and rare diseases Develops therapeutic strategies using microRNAs and biomarkers Collaborates with clinicians, engineers, and chemists for translational research His research integrates molecular pathology with clinical data through partnerships with Leeds NHS Trusts, aiming to identify novel biomarkers and targets for therapy. Recent work emphasizes cholesterol metabolism, oxysterol signaling, and nanomedicine-based drug delivery systems. Key contributions include: Over 80 peer-reviewed publications in cancer biology and molecular therapeutics Leadership in MSc programs in Molecular Medicine and Cancer Biology and Therapy Extensive experience in grant review, editorial work, and doctoral supervision Scientific awards include Fellowship of the Higher Education Academy. His lab has mentored 26 doctoral students and numerous alumni in academia, clinical practice, and industry.
Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.
